FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034870004> ?p ?o ?g. }

• W2034870004 abstract "Hexarelin, a powerful GH-releasing peptide, is capable of causing profound GH release in normal subjects after oral, intranasal, i.v., and s.c. administration. The effect of long-term administration on GH levels in adults is unknown. We have, therefore, assessed the effects of 16 weeks of twice-daily s.c. hexarelin therapy (1.5 micrograms/kg BW) on the GH response to a single injection of hexarelin, and also the GH response to hexarelin 4 weeks after cessation of hexarelin therapy. We have also assessed the effects of chronic hexarelin therapy on serum insulin-like growth factor (IGF)-I, IGF binding protein-3, markers of bone formation (osteocalcin, procollagen-type-III-N-terminal-peptide, and C-terminal propeptide of type I collagen), and resorption (urinary deoxypyridinoline and pyridinoline), body composition, and bone mineral density. The mean (+/- SEM) area under the GH curve (AUCGH) at weeks 0, 1, 4, 16, and 20 were 19.1 +/- 2.4 micrograms/L.h, 13.1 +/- 2.3 micrograms/L.h, 12.3 +/- 2.4 micrograms/L.h, 10.5 +/- 1.8 micrograms/L.h, and 19.4 +/- 3.7 micrograms/L.h, respectively. There was a significant change in AUCGH over the study period (P = 0.0003). Further analysis showed that, compared with baseline, the decrease in AUCGH at week 4 and week 16 were significant (P < 0.05 and P < 0.01, respectively). Four weeks after completion of hexarelin therapy, the AUCGH increased significantly, compared with AUCGH at week 16 (P < 0.05), and was not significantly different from that at week 0. Serum IGF-I and IGF binding protein-3 did not change significantly over the 20-week period (P = 0.24 and P = 0.74, respectively). Of the bone markers measured, only serum C-terminal propeptide of type I collagen changed significantly and was higher at week 16, compared with baseline (P = 0.019). Total body fat, lean body mass, and bone mineral density had not changed significantly at week 16, compared with baseline (P = 0.6, P = 0.3, and P = 0.3, respectively). In summary, we have demonstrated that chronic hexarelin therapy results in a partial and reversible attenuation of the GH response to hexarelin. In the present study, the biological impact of this hexarelin schedule on the GH-IGF-I axis seems to be minimal. The therapeutic potential of chronic hexarelin requires further investigation." @default.
• W2034870004 created "2016-06-24" @default.
• W2034870004 creator A5009497247 @default.
• W2034870004 creator A5071830224 @default.
• W2034870004 creator A5078913583 @default.
• W2034870004 date "1998-05-01" @default.
• W2034870004 modified "2023-09-23" @default.
• W2034870004 title "Growth Hormone Status during Long-Term Hexarelin Therapy" @default.
• W2034870004 cites W1967664560 @default.
• W2034870004 cites W1972083618 @default.
• W2034870004 cites W1986402890 @default.
• W2034870004 cites W1987910229 @default.
• W2034870004 cites W1988850160 @default.
• W2034870004 cites W1993294837 @default.
• W2034870004 cites W1997993870 @default.
• W2034870004 cites W2003659675 @default.
• W2034870004 cites W2009779774 @default.
• W2034870004 cites W2022110333 @default.
• W2034870004 cites W2028182259 @default.
• W2034870004 cites W2030484442 @default.
• W2034870004 cites W2038718736 @default.
• W2034870004 cites W2040898988 @default.
• W2034870004 cites W2042706359 @default.
• W2034870004 cites W2049144714 @default.
• W2034870004 cites W2054548024 @default.
• W2034870004 cites W2073025986 @default.
• W2034870004 cites W2080865659 @default.
• W2034870004 cites W2082857875 @default.
• W2034870004 cites W2085239741 @default.
• W2034870004 cites W2086148263 @default.
• W2034870004 cites W2086491300 @default.
• W2034870004 cites W2091767584 @default.
• W2034870004 cites W2134127282 @default.
• W2034870004 cites W2134717460 @default.
• W2034870004 cites W2141978541 @default.
• W2034870004 cites W2150568686 @default.
• W2034870004 cites W2153685825 @default.
• W2034870004 cites W2154712906 @default.
• W2034870004 cites W2161622680 @default.
• W2034870004 cites W2165675667 @default.
• W2034870004 cites W2166195826 @default.
• W2034870004 cites W2168212337 @default.
• W2034870004 cites W2315987042 @default.
• W2034870004 cites W2331609610 @default.
• W2034870004 cites W2408119528 @default.
• W2034870004 doi "https://doi.org/10.1210/jcem.83.5.4812" @default.
• W2034870004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9589671" @default.
• W2034870004 hasPublicationYear "1998" @default.
• W2034870004 type Work @default.
• W2034870004 sameAs 2034870004 @default.
• W2034870004 citedByCount "38" @default.
• W2034870004 countsByYear W20348700042015 @default.
• W2034870004 countsByYear W20348700042016 @default.
• W2034870004 countsByYear W20348700042017 @default.
• W2034870004 countsByYear W20348700042018 @default.
• W2034870004 crossrefType "journal-article" @default.
• W2034870004 hasAuthorship W2034870004A5009497247 @default.
• W2034870004 hasAuthorship W2034870004A5071830224 @default.
• W2034870004 hasAuthorship W2034870004A5078913583 @default.
• W2034870004 hasBestOaLocation W20348700041 @default.
• W2034870004 hasConcept C126322002 @default.
• W2034870004 hasConcept C131075544 @default.
• W2034870004 hasConcept C134018914 @default.
• W2034870004 hasConcept C160160445 @default.
• W2034870004 hasConcept C181199279 @default.
• W2034870004 hasConcept C185592680 @default.
• W2034870004 hasConcept C2778588143 @default.
• W2034870004 hasConcept C2780787237 @default.
• W2034870004 hasConcept C55493867 @default.
• W2034870004 hasConcept C673006 @default.
• W2034870004 hasConcept C71924100 @default.
• W2034870004 hasConceptScore W2034870004C126322002 @default.
• W2034870004 hasConceptScore W2034870004C131075544 @default.
• W2034870004 hasConceptScore W2034870004C134018914 @default.
• W2034870004 hasConceptScore W2034870004C160160445 @default.
• W2034870004 hasConceptScore W2034870004C181199279 @default.
• W2034870004 hasConceptScore W2034870004C185592680 @default.
• W2034870004 hasConceptScore W2034870004C2778588143 @default.
• W2034870004 hasConceptScore W2034870004C2780787237 @default.
• W2034870004 hasConceptScore W2034870004C55493867 @default.
• W2034870004 hasConceptScore W2034870004C673006 @default.
• W2034870004 hasConceptScore W2034870004C71924100 @default.
• W2034870004 hasLocation W20348700041 @default.
• W2034870004 hasLocation W20348700042 @default.
• W2034870004 hasOpenAccess W2034870004 @default.
• W2034870004 hasPrimaryLocation W20348700041 @default.
• W2034870004 hasRelatedWork W1966315831 @default.
• W2034870004 hasRelatedWork W1967422973 @default.
• W2034870004 hasRelatedWork W2034870004 @default.
• W2034870004 hasRelatedWork W2039435952 @default.
• W2034870004 hasRelatedWork W2041317798 @default.
• W2034870004 hasRelatedWork W2053638911 @default.
• W2034870004 hasRelatedWork W2058465507 @default.
• W2034870004 hasRelatedWork W2067199708 @default.
• W2034870004 hasRelatedWork W2076169802 @default.
• W2034870004 hasRelatedWork W2122242665 @default.
• W2034870004 isParatext "false" @default.
• W2034870004 isRetracted "false" @default.
• W2034870004 magId "2034870004" @default.
• W2034870004 workType "article" @default.